Effect of Geranti Bio-Ge Yeast, a Dried Yeast Containing Biogermanium, on the Production of Antibodies by B Cells

B 세포의 항체 생산에 대한 게란티 바이오-게르마늄 효모의 영향

  • Joo, Seong-Soo (Department of Immunology, College of Pharmacy, Chung-Ang University) ;
  • Won, Tae-Joon (Department of Immunology, College of Pharmacy, Chung-Ang University) ;
  • Lee, Yong-Jin (Department of Immunology, College of Pharmacy, Chung-Ang University) ;
  • Kim, Min-Jung (Department of Immunology, College of Pharmacy, Chung-Ang University) ;
  • Park, So-Young (Department of Cell and Molecular Biology, Feinberg School of Medicine and Institute of Neuroscience, Northwestern University) ;
  • Lee, Sung-Hee (GerantiPharm LTD) ;
  • Lee, Do-Ik (Department of Immunology, College of Pharmacy, Chung-Ang University) ;
  • Hwang, Kwang-Woo (Department of Immunology, College of Pharmacy, Chung-Ang University)
  • 주성수 (중앙대학교 약학대학 면역학교실) ;
  • 원태준 (중앙대학교 약학대학 면역학교실) ;
  • 이용진 (중앙대학교 약학대학 면역학교실) ;
  • 김민정 (중앙대학교 약학대학 면역학교실) ;
  • 박소영 (노스웨스턴대학교 의과대학 세포분자 신경연구소) ;
  • 이성희 (게란티제약㈜) ;
  • 이도익 (중앙대학교 약학대학 면역학교실) ;
  • 황광우 (중앙대학교 약학대학 면역학교실)
  • Published : 2006.06.30

Abstract

Background: Germanium compounds are increased to use in nutrient foods and medicines in terms of antibiotics to microbes, anticancer, modulation of immune system and neutralizing heavy metal toxins. Geranti Bio-Ge Yeast, containing stable organic germanium and bound to the yeast protein was developed by Geranti Pharm. LTD. and the modulation effect in the immune system was examined in vivo and in vitro. Methods: The compound, Geranti Bio-Ge Yeast, was fed to female Balb/c mice (each group has 10 mice) for 4 weeks and the yeast powder and steamed red ginseng powder were used as control during the same feeding time points. During 4 weeks there was no symptom to be considered, and after 4 weeks feeding all mice were sacrificed to check the changes of related immune cells and subsidiary responses (i.e. cell counting, FACS, MTT, LDH, PFC assay). Results: In pre-post comparison, B cell population was increased in the group of Geranti Bio-Ge Yeast in a dose dependent manner (100 to 800 mg/kg). However, the population of T cell, dendritic cell and macrophage was not comparably changed in all doses. The ability of cytokine production and proliferation was almost same level as shown in control group. In contrast, PFC assay informed that the compound increase the antibody production ability when fed over 200 mg/kg implying that the increase of PFC number might be due to the increase of B cells. Conclusion: Over the entire study, we concluded that the compound, Geranti Bio-Ge Yeast has better potential in immune response in terms of B cell proliferation than that of positive control, red ginseng, and the compound can be one of the future candidates for a new supplementary source improving immune system activity.

Keywords

References

  1. Goodman S: Therapeutic effect of organic germanium. Med Hypothesis 26;207-215, 1988 https://doi.org/10.1016/0306-9877(88)90101-6
  2. Tsutsumi Y, Tanaka J, Kanamori H, Musashi M, Minami H, Fukushima A, Yamato H, Ehira N, Kawamura T, Obara S, Ogura N, Asaka M, Imamura M, Masauzi N: Effectiveness of propagermanium treatment in multiple myeloma patients. Eur J Haematol 73;397-401, 2004 https://doi.org/10.1111/j.1600-0609.2004.00330.x
  3. Krystek P, Ritsema R: Analytical product study of germanium- containing medicine by different ICP-MS application. J Trace Med Biol 18;9-16, 2004 https://doi.org/10.1016/j.jtemb.2004.04.003
  4. Cavalieri D, McGovern PE, Hartl DL, Mortimer R, Polsinelli M: Evidence for S. cerevisiae fermentation in ancient wine. J Mol Evol 57;226-232, 2003 https://doi.org/10.1007/s00239-003-0031-2
  5. Tuite MF: Strategies for the genetic manipulation of Saccharomyces cerevisiae. Crit Rev Biotechnol 12;157-188, 1992 https://doi.org/10.3109/07388559209069191
  6. Vera J, Parissi V, Garcia A, Zuniga R, Andreola ML, Caumont- Sarcos A, Tarrago-Litvak L, Leon O: Yeast system as a model to study mononey murine leukemia virus integrase: expression, mutagenesis and sratch for eukaryotic partners. J Gen Virol 86;2481-2488, 2005 https://doi.org/10.1099/vir.0.81006-0
  7. Kumura H, Tanoue Y, Tsukahara M, Tanaka T, Shimazaki K: Screening of diary yeast strains for probiotic applications. J Dairy Sci 87;4050-4056, 2004 https://doi.org/10.3168/jds.S0022-0302(04)73546-8
  8. Xing LJ, Li D, Wang X, Zhao L, Lv S, Huang D: Effects of beta-glucal extracted from saccharomyces cerevisiae on humoral and cellular immunity in weaned piglets. Arch Anim Nutr 59;303-312, 2005 https://doi.org/10.1080/17450390500247832
  9. Peng M, Chen M, Ling N, Xu H, Qing Y, Ren H: Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70. Vaccine 24;887-896, 2006 https://doi.org/10.1016/j.vaccine.2005.12.050
  10. Facchinetti F, Nappi RE, Sances MG, Neri I, Grandinetti G, Genazzani A: Effects of a yeast-diatary supplementation on premenstrual syndrome. A double-blind placebo-controlled study. Gynecol Obstet Invest 43;120-124, 1997 https://doi.org/10.1159/000291836
  11. Hirayama C, Suzuki, IM, Okumura M, Oda T: Propagermanium: a nonspecific immune modulator for chronic hepatitis B. J Gastroenterol 38;525-532, 2003 https://doi.org/10.1007/s00535-003-1098-7
  12. Lee JS, Park JI, Kim Sh, Park SH, Kang SK, Park CB, Sohn TU, Jang JY, Kang JK, Kim YB: Oral single- and repeated- dose toxicity studies on Geranti Bio-Ge yeast, organic germanium fortified yeast, in rats. J Toxicol Sci 29; 541-553, 2004 https://doi.org/10.2131/jts.29.541
  13. Lee JS, Park JI, Kim SH, Lee HY, Hwang ZZ, Park CB, Sohn TU, Shin S, Kang JK, Kim YB: Oral single- and repeated-dose toxicity studies on Geranti Bio-Ge yeast, organic germanium fortified yeast, in dogs. J Toxicol Sci 29;555-569, 2004 https://doi.org/10.2131/jts.29.555
  14. Wilson SD, Munson AE, Meade BJ: Assessment of the functional integrity of the humoral immune response: the plaque-forming cell assay and the enzyme-linked immunosorbent assay. Methods 19;3-7, 1999 https://doi.org/10.1006/meth.1999.0821